-DOCSTART- -X- O
Cell -X- _ O
death -X- _ O
plays -X- _ O
a -X- _ O
crucial -X- _ O
role -X- _ O
for -X- _ O
a -X- _ O
myriad -X- _ O
of -X- _ O
physiological -X- _ O
processes -X- _ O
, -X- _ O
and -X- _ O
several -X- _ O
human -X- _ B-Patient
diseases -X- _ I-Patient
such -X- _ I-Patient
as -X- _ I-Patient
cancer -X- _ I-Patient
are -X- _ O
characterized -X- _ O
by -X- _ O
its -X- _ O
deregulation. -X- _ O
There -X- _ O
are -X- _ O
many -X- _ O
methods -X- _ O
available -X- _ O
for -X- _ O
both -X- _ O
quantifying -X- _ O
and -X- _ O
qualifying -X- _ O
the -X- _ O
accurate -X- _ O
process -X- _ O
of -X- _ O
cell -X- _ O
death -X- _ O
which -X- _ O
occurs. -X- _ O
Choosing -X- _ O
the -X- _ O
right -X- _ O
assay -X- _ O
tool -X- _ O
is -X- _ O
essential -X- _ O
to -X- _ O
generate -X- _ O
meaningful -X- _ O
data -X- _ O
, -X- _ O
provide -X- _ O
sufficient -X- _ O
information -X- _ O
for -X- _ O
clinical -X- _ O
applications -X- _ O
, -X- _ O
and -X- _ O
understand -X- _ O
cell -X- _ O
death -X- _ O
processes. -X- _ O
In -X- _ B-Intervention
vitro -X- _ I-Intervention
cell -X- _ I-Intervention
death -X- _ I-Intervention
assays -X- _ I-Intervention
are -X- _ O
important -X- _ O
steps -X- _ O
in -X- _ O
the -X- _ O
search -X- _ O
for -X- _ O
new -X- _ O
therapies -X- _ O
against -X- _ O
cancer -X- _ O
as -X- _ O
the -X- _ O
ultimate -X- _ O
goal -X- _ O
remains -X- _ O
the -X- _ O
elaboration -X- _ O
of -X- _ O
drugs -X- _ O
that -X- _ O
interfere -X- _ O
with -X- _ O
specific -X- _ O
cell -X- _ O
death -X- _ O
mechanisms. -X- _ O
However -X- _ O
, -X- _ O
choosing -X- _ O
a -X- _ O
cell -X- _ O
viability -X- _ O
or -X- _ O
cytotoxicity -X- _ O
assay -X- _ O
among -X- _ O
the -X- _ O
many -X- _ O
available -X- _ O
options -X- _ O
is -X- _ O
a -X- _ O
daunting -X- _ O
task. -X- _ O
Indeed -X- _ O
, -X- _ O
cell -X- _ O
death -X- _ O
can -X- _ O
be -X- _ O
approached -X- _ O
by -X- _ O
several -X- _ O
viewpoints -X- _ O
and -X- _ O
require -X- _ O
a -X- _ O
more -X- _ O
holistic -X- _ O
approach. -X- _ O
This -X- _ O
review -X- _ O
provides -X- _ O
an -X- _ O
overview -X- _ O
of -X- _ O
cell -X- _ B-Outcome
death -X- _ I-Outcome
assays -X- _ I-Outcome
usually -X- _ I-Outcome
used -X- _ I-Outcome
in -X- _ I-Outcome
vitro -X- _ I-Outcome
for -X- _ I-Outcome
assessing -X- _ I-Outcome
cell -X- _ I-Outcome
death -X- _ I-Outcome
so -X- _ O
as -X- _ O
to -X- _ O
elaborate -X- _ O
new -X- _ O
potential -X- _ O
chemotherapeutics -X- _ O
and -X- _ O
discusses -X- _ O
considerations -X- _ O
for -X- _ O
using -X- _ O
each -X- _ O
assay -X- _ O
. -X- _ O

